In this study, we demonstrated that mitochondrial fission defects caused by the lack of DRP1 lead to tissue damage associated with hepatitis, which suggests that DRP1 could be a therapeutic target for inflammatory liver disease. Here, DNM1L is linked to hepatitis A virus infection.